Health
Clinical trials of hydroxychloroquine in COVID-19 outpatients reported as safe – News-Medical.Net
According to new research, the use of hydroxychloroquine among outpatients in clinical trials, without high-risk factors for cardiac arrhythmia, is safe.
According to new research published in the preprint server medRxiv* in July 2020, the use of hydroxychloroquine (HCQ) among outpatients in clinical trials, without high-risk factors for cardiac arrhythmia, is safe, with gastrointestinal side-effects being the most common side effects and no fatal adverse outcomes.
As the COVID-19 pandemic continues all around the world, with over 630,000 deaths so far, scientific research has focused on finding effective medications against the virus. A strong …
-
Noosa News16 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General17 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General14 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
Noosa News17 hours agoThe Best Things to Do in Brisbane This New Year’s Eve